The newly created AMU Research Institute for Precision Medicine will establish an interdisciplinary basic and translational cancer and diabetes research program to meet growing challenges facing UAE health care providers dealing with the increase in cancer burden and diabetes disease. It will focus its activities on comprehensive, translational research and personalised medicine, aims to become a centre of excellence and a leader in developing personalised medicine in the region. The centre will concentrate its activities on the development of state-of-the-art research technology platforms (liquid biopsy, NGS, functional genomics, imaging, gene editing) fundamental to position the centre in the international scene research field and as a regional leader in personalized cancer immunotherapy. Our ultimate goal is to position GMU among the leading research universities and a national model for medical education in the region by integrating innovation through research.